Michael Mansour, M.D., Ph.D.
|
| Harvard Medical School |
| Associate Professor of Medicine |
| Affiliations: |
|
| 1 |
Transplant Infectious Diseases and Immunocompromised Host Service
Division of Infectious Diseases, Department of Medicine
Massachusetts General Hospital, Boston, Massachusetts |
| 2 |
Associate Member, Broad Institute of MIT and Harvard,
Cambridge, MA |
| 3 |
Affiliated Member, Harvard Stem Cell Institute, Boston, MA |
| |
| Brief Bio: |
Graduated with MD/Ph.D. dual degrees from Boston University School of Medicine with a research concentration in immune responses against invading pathogens. He completed his medical residency at the Massachusetts General Hospital (MGH) in Boston, MA, where he also served as a Chief resident before completing the Harvard combined Infectious Diseases training program at the MGH and the Brigham and Women’s Hospital. Dr. Mansour joined the MGH ID faculty in 2014 and now attends on
the clinical Transplant Infectious Diseases and Immunocompromised Host Service, where he cares for solid and stem cell transplant recipients and those individuals with weakened immunity. Dr. Mansour is an investigator overseeing a laboratory focusing on innate immune responses to infectious pathogens. He maintains funding through NIH grants, the US Department of Defense, and industry sponsors. The research objectives of his laboratory are innate immune (neutrophil) responses to invasive infections, specifically fungal pathogens, such as Candida, Aspergillus, and other invasive mold species. He directs several immunology and infectious diseases clinical trials aimed at using biomarkers for immune profiling patients for improved prognostication and risk stratification. Dr. Mansour also focuses on healthier infectious disease-resilient environments for susceptible patients. His work has contributed to several technological advances centered on generating neutrophils as cellular therapies and immune augmentation. Dr. Mansour has received numerous awards, including the Thomas J. Walsh Young Investigator Award from the Medical Mycological Society of the Americas, the Morton Swartz Transformative Scholar Award in Infectious Diseases, and the Maxwell Finland Award for Research Excellence. Finally, Dr. Mansour sits on several committees and research programs to develop treatment guidelines for transplant infectious diseases and immunomodulatory treatments. |
